More Than 75 Biotechs Adopt Veeva Basics
Veeva Systems, a leading provider of cloud software for the life sciences sector, recently announced a significant achievement: over 75 emerging biotech firms are now utilizing Veeva Basics. This software solution is designed to ensure efficiency and cost reduction across clinical trials, regulatory submissions, and quality control processes.
What sets Veeva Basics apart is its ability to provide standardized applications that allow biotechs to implement industry-leading software solutions within weeks. The rapid adoption of this tool indicates a notable transition from fragmented entry-level tools to comprehensive, best-in-class solutions that can flexibly support biotechs as they grow.
Designed for Fast Growth
Veeva Basics is specifically tailored for dynamic and fast-growing companies. It offers pre-configured and pre-validated software, enabling rapid deployment regardless of a company's size. Currently, Veeva is expanding its offerings by introducing two new applications catering specifically to the needs of biotech companies:
- - Veeva CTMS Basics: A clinical trial management system that addresses critical elements such as milestones, monitoring, enrollment processes, issue resolution, and site communications.
- - Veeva Submissions Publishing Basics: A streamlined solution for constructing, publishing, and transmitting regulatory submissions, all consolidated in a single system.
Steve Harper, the general manager of Veeva Basics, stated, “The increasing number of biotechs adopting Veeva Basics in North America and Europe showcases the significant savings in time, costs, and operational effort. Our focus on providing pre-configured, quickly deployable solutions is resonating well with the rapidly expanding biotech sector.”
Biotech Voices on Veeva Basics
The impact of Veeva Basics on biotech companies has been remarkable, according to various industry experts:
- - Ian Hodgson, Ph.D., COO of Corbus Pharmaceuticals, remarked, “Veeva Basics is a game changer, offering smaller biotech firms access to modern, connected applications typically reserved for larger organizations. This adaptability as we scale is vital for meeting evolving regulatory standards.”
- - Joe Thornton, Associate Director of Clinical Operations at Scancell, highlighted that “Veeva eTMF Basics provides enhanced control over our data and processes, ensuring we are always prepared for inspections. Using a solution with pre-configured best practices fuels our speed and innovation in developing novel immunotherapies.”
- - Rebecca Deng, Ph.D., Associate Director of Regulatory Affairs and QA Systems at Terns Pharmaceuticals, added, “The comprehensive support and training with Veeva Basics allows us to maximize the value from Veeva's industry solutions. Their straightforward path to validation has saved us significant time and resources.”
The Future with Veeva
Veeva Basics is not only available across North America and Europe, but it is also built on the established Vault Platform, which allows clients to scale their technology infrastructure concurrently with their growth.
As Veeva Systems continues to innovate and enhance its offerings, it remains committed to delivering cloud-based solutions that meet the evolving needs of the life sciences sector. As more biotech companies pivot towards advanced technologies, the implementation of Veeva Basics is set to revolutionize their operational efficiencies.
For more detailed information on Veeva Basics, interested parties can visit
veeva.com/VeevaBasics, where additional resources and insights are available.
Overall, the move towards Veeva Basics is not just a trend; it's indicative of a profound shift towards integrated, efficient solutions that empower biotech firms to thrive in a competitive landscape. As the life sciences domain continues to evolve, one thing is certain: Veeva Basics will play a pivotal role in shaping the future of biotech operations.